9 CHAPTER 1 General introduction and outline of the thesis Part One Cisplatin-induced acute kidney injury CHAPTER 2 Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin Part Two Chemotherapy-induced nausea and vomiting CHAPTER 3 Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic motherapy: a systematic review of randomized controlled trials CHAPTER 4 Metoclopramide, dexamethasone, or palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting after moderately emetogenic chemotherapy (MEDEA): a randomized, phase III, noninferiority trial Part Three Delirium CHAPTER 5 Identification of patients with cancer with a high risk to develop delirium CHAPTER 6 Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer CHAPTER 7 Olanzapine vs. haloperidol for treatment of delirium in patients with advanced cancer – a phase III randomized clinical trial CHAPTER 8 Summarizing discussion and future perspectives Appendices Dutch summary (Nederlandse samenvatting) Acknowledgments (Dankwoord) About the author (Curriculum vitae) Bibliography 10 30 50 66 88 108 120 142 158 164 168 170
RkJQdWJsaXNoZXIy MjY0ODMw